Whole Blood Donation Affects the Interpretation of Hemoglobin A1c

• Published in: PloS one Vol. 12; no. 1; p. e0170802
• Main Authors: Dijkstra, Angelique, Lenters-Westra, Erna, de Kort, Wim, Bokhorst, Arlinke G., Bilo, Henk J. G., Slingerland, Robbert J., Vos, Michel J.
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01.01.2017; Public Library of Science (PLoS)
• Subjects: Aged; Biology and life sciences; Blood; Blood & organ donations; Blood banks; Blood Donors; Blood Proteins - analysis; Chemistry; Data analysis; Demographics; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - drug therapy; Erythrocytes; Erythropoiesis; Female; Ferritin; Ferritins - blood; Forecasting; Glucose; Glycated Hemoglobin A - analysis; Hematology; Hemoglobin; Humans; Hypoglycemic Agents - therapeutic use; Internal medicine; Iron; Laboratories; Male; Medicine and health sciences; Metabolism; Metformin - therapeutic use; Middle Aged; Observational studies; Prospective Studies; Reduction; Vitamins - blood
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0170802

Several factors, including changed dynamics of erythrocyte formation and degradation, can influence the degree of hemoglobin A1c (HbA1c) formation thereby affecting its use in monitoring diabetes. This study determines the influence of whole blood donation on HbA1c in both non-diabetic blood donors and blood donors with type 2 diabetes. In this observational study, 23 non-diabetic blood donors and 21 blood donors with type 2 diabetes donated 475 mL whole blood and were followed prospectively for nine weeks. Each week blood samples were collected and analyzed for changes in HbA1c using three secondary reference measurement procedures. Twelve non-diabetic blood donors (52.2%) and 10 (58.8%) blood donors with type 2 diabetes had a significant reduction in HbA1c following blood donation (reduction >-4.28%, P < 0.05). All non-diabetic blood donors with a normal ferritin concentration predonation had a significant reduction in HbA1c. In the non-diabetic group the maximum reduction was -11.9%, in the type 2 diabetes group -12.0%. When eligible to donate again, 52.2% of the non-diabetic blood donors and 41.2% of the blood donors with type 2 diabetes had HbA1c concentrations significantly lower compared to their predonation concentration (reduction >-4.28%, P < 0.05). Patients with type 2 diabetes contributing to whole blood donation programs can be at risk of falsely lowered HbA1c. This could lead to a wrong interpretation of their glycemic control by their general practitioner or internist.